Sam's questions to Regeneron Pharmaceuticals Inc (REGN) leadership • Q4 2024
Question
Sam, on behalf of Christopher Raymond at Piper Sandler, asked about the pricing strategy for EYLEA following a modest price increase, and whether the goal is to stabilize the average sale price.
Answer
CEO Dr. Leonard Schleifer and EVP of Commercial Marion McCourt both declined to comment on pricing strategy. McCourt clarified that a modest price increase was applied to EYLEA HD.